India to Mali: Albendazole Export Trade Route
India has recorded 71 verified shipments of Albendazole exported to Mali, representing a combined trade value of $2.5M USD. This corridor is served by 24 active Indian exporters, with an average shipment value of $35.7K USD. The leading Indian exporter is CAPLIN POINT LABORATORIES LIMITED, which accounts for 80% of total export value with 2 shipments worth $2.0M USD. On the buying side, PHARMA PLUS MALI, S.A. is the largest importer in Mali with $2.0M USD in purchases. The top 3 suppliers — CAPLIN POINT LABORATORIES LIMITED, GLOW PHARMA PRIVATE LIMITED, CAPLIN POINT LABORATORIES LIMITED — together control 93% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Mali Albendazole corridor is one of India's established pharmaceutical export routes, with 71 shipments documented worth a combined $2.5M USD. The route is dominated by CAPLIN POINT LABORATORIES LIMITED, which alone accounts for roughly 80% of all export value, reflecting the consolidated nature of India's albendazole manufacturing sector.
Across 24 active suppliers, the average shipment value stands at $35.7K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 85% of all shipments, consistent with albendazole's non-urgent bulk-order profile.
Shipment activity peaks during January–March, with an average transit time of 33 days port-to-port. The route has recorded an annual growth rate of 12.0%, placing it at rank #10 among India's top albendazole export destinations globally.
On the import side, key buyers of Indian albendazole in Mali include PHARMA PLUS MALI, S.A., PHARMA PLUS MALI, S.A. , WORLD VISION MALI and 26 others. PHARMA PLUS MALI, S.A. is the single largest importer with 2 shipments valued at $2.0M USD.
